Structural and functional changes of the contractile proteins in experimentally-induced cardiac hypertrophy in animals, and heart failure in man.
D000109:Acetylcholine / Q000494:pharmacology; D000205:Actomyosin / Q000378:metabolism; D000251:Adenosine Triphosphatases / Q000378:metabolism*; D000818:Animals; D001024:Aortic Valve Stenosis / Q000201:enzymology* / Q000503:physiopathology; D006332:Cardiomegaly / Q000201:enzymology* / Q000503:physiopathology; D003864:Depression, Chemical; D004285:Dogs; D004789:Enzyme Activation; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008297:Male; D008944:Mitral Valve Insufficiency / Q000201:enzymology* / Q000503:physiopathology; D008946:Mitral Valve Stenosis / Q000201:enzymology; D009124:Muscle Proteins / Q000378:metabolism*; D005082:Physical Exertion; D011817:Rabbits; D013268:Stimulation, Chemical; D013328:Strophanthins / Q000494:pharmacology; D013997:Time Factors
D009124:Muscle Proteins; D013328:Strophanthins; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D000109:Acetylcholine